FDA Gets Some Recommendations
Prompted by the dangers associated with Vioxx in 2004, the Food and Drug Administration (FDA) asked the Institute of Medicine to review their drug safety system. With the results in, the institute is recommending several changes.
Recommended changes that need... Read more »
FDA Budget Problems Could Increase Risks
The Food and Drug Administration (FDA) forgot one important factor when they began a study on the risks associated with attention-deficit hyperactivity drugs (ADHD) in children and adults—a budget. This FDA study and others like it may soon stop... Read more »
Jury Links Prempro to Woman’s Breast Cancer
A Philadelphia jury found that the hormone replacement therapy (HRT) drug Prempro was the cause of a woman’s breast cancer. The next phase of the trial will decide if Wyeth, Prempro’s maker, failed to properly warn about the... Read more »
Bayer Withheld Trasylol Study Findings
Last month, Bayer scientists met with the Food and Drug Administration (FDA) to discuss their heart-surgery drug, Trasylol, and its possible risks. But Bayer failed to mention that they already conducted a large study on the drug and the results... Read more »
Ortho Evra Label Updated for Greater Clot Risk
The controversial birth-control patch, Ortho Evra, will have more data concerning the drug’s risk on its label. Designed to replace taking a pill daily, the patch is applied only once a week. But studies show it carries... Read more »
Not All Drugs Are FDA-Approved
Just because your doctor has written a prescription for a certain drug and your pharmacy carries it, doesn’t necessarily mean it has been approved by the Food and Drug Administration (FDA). The FDA wants to get this message out to... Read more »
Acne Drug Gets Powerful Restrictions
Isotretinoin, more commonly known as Accutane, is getting harder and harder to come by after the government enforced strict rules to hopefully eliminate the drug’s dangerous side effects. The Food and Drug Administration (FDA) started a program known as iPledge,... Read more »
Is Arcoxia the Next Vioxx?
An arthritis drug Merck developed to replace Vioxx and compete with Celebrex may be just as dangerous, according to a whistle-blower from the Food & Drug Administration. In an editorial published in the Journal of American Medical Association website, David... Read more »
Antibiotic Linked to Skin Problems
The antibiotic Factive, also known as gemifloxacin, used to treat acute sinus infections has been linked to serious skin reactions, according to the Food and Drug Administration (FDA). Compared to similar antibiotics, the risk of rashes associated with Factive is... Read more »
Beware of Canadian Prescription Drug Websites
The U.S. Food and Drug Administration (FDA) is urging consumers not to purchase prescription drugs from Canadian websites that have orders filled by Mediplan Prescription Plus Pharmacy or Mediplan Global Health. The FDA has received reports of counterfeit drugs... Read more »
